Our perspective on AL/ML in the life sciences industry.
When Drugs and Devices Come Together, Safety Considerations Get More Complex Dr. Khaudeja Bano, Vice President Combination Product Quality at Amgen, joined the Safety Signals Podcast to discuss the
More than Just Paper Shuffling and Regulations Yvonne Nanciu joined the Safety Signals Podcast to explain how pharmacovigilance can be a rich and rewarding field.
Small Patient Populations Pose Unique Challenges for Safety Scientists Peter Hawkins, Senior Director, Head of Rare Genetic Disease Risk Management at Agios Pharmaceuticals, joined the
Emerging Professionals Must Understand Data Science and AI “The number one priority that I have at the moment is thinking about the PV professional of
As Data Explodes, Safety Scientists Need to Be More Tech Savvy Young people interested in a career in pharmacovigilance are learning about computer science and
What Does Drug Safety Mean from the Patient’s Perspective? Rakesh Raman, M.D., Senior Director, Head of Medical Safety at REVOLUTION Medicines, joined the Safety Signals
